XML 28 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Equity-Based Compensation
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]    
Equity-Based Compensation EQUITY-BASED COMPENSATION
A summary of equity-based compensation expense recognized during the three months ended December 31, 2019 and 2018 is as follows:
Three months ended December 31,
20192018
Stock options$2,124  $951  
Amounts are included in general and administrative expense on the condensed consolidated statements of operations. Income tax benefits of $148 were recognized during the three months ended December 31, 2019. No income tax benefits were recognized related to equity-based compensation during the three months ended December 31, 2018.
Stock Options
In May 2018, the Company adopted the 2018 Equity Incentive Plan (the “2018 Plan”) under which the Company may grant up to 3,500,000 stock options and other equity-based awards to employees, directors and officers. The number of shares of Class A common stock available for issuance under the 2018 Plan includes an annual increase on the first day of each year, beginning with the 2019 calendar year, equal to 4.0% of the outstanding shares of all classes of the Company's common stock as of the last day of the immediately preceding calendar year, unless the Company’s board of directors determines prior to the last trading day of December of
the immediately preceding calendar year that the increase shall be less than 4.0%. As of December 31, 2019, there were 165,088 equity awards available for grant under the 2018 Plan.
In connection with the IPO, the Company granted 2,045,000 stock options to its directors and certain employees. The stock options were granted with an exercise price of $13.00 per share and vest ratably over a three-year period.
The fair value of the stock option awards during the three months ended December 31, 2019 and from June 20, 2018 through September 30, 2019 was determined on the grant date using the Black-Scholes valuation model based on the following weighted-average assumptions:
December 31, 2019  September 30, 2019  
Expected volatility(1)
25.2 %26.7 %
Expected dividend yield(2)
— %— %
Expected term(3)
6 years6 years
Risk-free interest rate(4)
1.7 %2.5 %
_________________
1.Expected volatility is based on the historical volatility of a selected peer group over a period equivalent to the expected term.
2.The Company has assumed a dividend yield of zero as management has no plans to declare dividends in the foreseeable future.
3.Expected term represents the estimated period of time until an award is exercised and was determined using the simplified method.
4.The risk-free rate is an interpolation of yields on U.S. Treasury securities with maturities equivalent to the expected term.

A summary of stock option activity for the three months ended December 31, 2019 is as follows:
Stock Options
Weighted Average Exercise Price
Outstanding at beginning of period4,240,695  $18.33  
Granted159,000  23.92  
Exercised(103,964) 15.17  
Forfeited(30,665) 21.62  
Outstanding at end of period4,265,066  $18.60  
The weighted-average grant date fair value of stock options granted during the three months ended December 31, 2019 was $6.74. As of December 31, 2019, there were 4,265,066 stock options outstanding, of which 758,950 were exercisable. As of December 31, 2019, total unrecognized compensation expense related to unvested stock options, including an estimate for pre-vesting forfeitures, was $16,500, which is expected to be recognized over a weighted-average period of 2.1 years. The Company's policy is to account for forfeitures of stock-based compensation awards as they occur. The total fair value of stock options that vested during the three months ended December 31, 2019 was $1,751.
No